🇺🇸 Vigantol in United States
745 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 745
Most-reported reactions
- Fatigue — 94 reports (12.62%)
- Pyrexia — 94 reports (12.62%)
- General Physical Health Deterioration — 87 reports (11.68%)
- Vomiting — 77 reports (10.34%)
- Nausea — 74 reports (9.93%)
- Dyspnoea — 70 reports (9.4%)
- Asthenia — 68 reports (9.13%)
- Pneumonia — 62 reports (8.32%)
- Diarrhoea — 60 reports (8.05%)
- Abdominal Pain — 59 reports (7.92%)
Other Other approved in United States
Frequently asked questions
Is Vigantol approved in United States?
Vigantol does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Vigantol in United States?
Karolinska University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.